Aqueous flow in human eyes is reduced by forskolin, a potent adenylate cyclase activator-Reference-Cited by-同舟云学术

Aqueous flow in human eyes is reduced by forskolin, a potent adenylate cyclase activator

Published:1984-12 Issue:6 Volume:39 Page:745-749
ISSN:0014-4835
Container-title:Experimental Eye Research
language:en
Short-container-title:Experimental Eye Research

Author:

Burstein Neal L.,Sears Marvin L.,Mead Alden

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference22 articles.

1. Forskolin: an experimental drug which stimulates cyclic AMP synthesis in vitro and decreases intraocular pressure after topical administration;Bartels;Invest. Ophthalmol. Vis. Sci. Suppl.,1984

2. Forskolin lowers intraocular pressure in rabbits, monkeys, and man;Caprioli;The Lancet,1983

3. Combined effect of forskolin and acetazolamide on intraocular pressure and aqueous humor flow in rabbit eyes;Caprioli;Exp. Eye Res.,1984

4. Forskolin lowers intraocular pressure by reducing aqueous inflow;Caprioli;Invest. Ophthalmol. Vis. Sci.,1984

5. Cyclic 3′,5′-adenosine monophosphate in the choroid plexus: stimulation by cholera toxin;Cramer;Biochem. Biophys. Res. Commun.,1978

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotective Effect of a Nutritional Supplement Containing Spearmint Extract, Forskolin, Homotaurine and Group B Vitamins in a Mouse Model of Transient Ocular Hypertension;Biomedicines;2023-05-18

2. Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma;Nutrients;2020-10-16

3. Development of low-cost plant probiotic formulations of functional endophytes for sustainable cultivation of Coleus forskohlii;Microbiological Research;2019-10

4. Chitosan coated PLGA nanoparticles amplify the ocular hypotensive effect of forskolin: Statistical design, characterization and in vivo studies;International Journal of Biological Macromolecules;2018-09

5. Rational Basis for Nutraceuticals in the Treatment of Glaucoma;Current Neuropharmacology;2018-07-12